• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  FDA Gives Pamrevlumab Orphan Drug Status

  Posted by MD forums Moderator on April 24, 2019 at 8:31 am

  The FDA has named pamrevlumab, a potential anti-fibrosis treatment by FibroGen now in a Phase 2 trial for non-ambulatory DMD patients, an orphan drug. Read more about this decision here.

  What are your thoughts on this news?

  replied 6 years, 10 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply